Adverum Biotechnologies, Inc. (ADVM)

NASDAQ: ADVM · IEX Real-Time Price · USD

11.34

+0.19 (1.70%)

At close: Apr 19, 2024, 4:00 PM

11.70

+0.36 (3.17%)

After-hours: Apr 19, 2024, 7:34 PM EDT

Adverum Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Cash & Equivalents	76.98	70.93	36.7	63.42	66.9	155.95	70.52	222.17	221.35	159.4	Upgrade
Short-Term Investments	21.53	117.16	270.99	367.31	100.14	50.13	119.97	0	37.73	0	Upgrade
Cash & Cash Equivalents	98.5	188.09	307.69	430.73	167.03	206.08	190.49	222.17	259.08	159.4	Upgrade
Cash Growth	-47.63%	-38.87%	-28.56%	157.87%	-18.95%	8.19%	-14.26%	-14.25%	62.53%	28163.12%	Upgrade
Receivables	0	0	6.48	0	0	0	0	0.89	0.45	0	Upgrade
Other Current Assets	4.27	2.5	2.98	3.71	8.84	2.68	3.26	2.22	1.46	0.87	Upgrade
Total Current Assets	102.77	190.6	317.15	434.44	175.87	208.75	193.74	225.27	260.99	160.28	Upgrade
Property, Plant & Equipment	67.03	113.86	119.06	47.1	45.85	3.59	3.02	4.17	3.19	1.09	Upgrade
Goodwill and Intangibles	0	0	0	0	0	0	5	5	0	0	Upgrade
Other Long-Term Assets	3.21	3.92	3.52	1.03	1.01	1.16	0.14	0.14	0.14	0.54	Upgrade
Total Long-Term Assets	70.24	117.78	122.58	48.13	46.86	4.74	8.16	9.31	3.33	1.63	Upgrade
Total Assets	173.01	308.37	439.73	482.57	222.73	213.5	201.91	234.58	264.32	161.91	Upgrade
Accounts Payable	1.92	2.24	1.39	2.81	4.1	1.71	1.73	1.47	0.61	0.95	Upgrade
Deferred Revenue	0	0	0	0	0	0	7.1	8.95	5.59	7.46	Upgrade
Other Current Liabilities	22.99	30.01	19.93	18.06	15.31	9.01	1.84	-0.53	0.38	-2.94	Upgrade
Total Current Liabilities	24.91	32.25	21.32	20.87	19.41	10.72	10.67	9.9	6.57	5.47	Upgrade
Long-Term Debt	64.63	93.56	101.11	26.24	28.21	0	0	0	0	0	Upgrade
Other Long-Term Liabilities	0	1.05	1.11	1.11	0.15	1.61	7.2	9.09	5.15	6.95	Upgrade
Total Long-Term Liabilities	64.63	94.61	102.22	27.35	28.36	1.61	7.2	9.09	5.15	6.95	Upgrade
Total Liabilities	89.54	126.85	123.54	48.22	47.77	12.33	17.88	18.98	11.73	12.42	Upgrade
Total Debt	64.63	93.56	101.11	26.24	28.21	0	0	0	0	0	Upgrade
Debt Growth	-30.93%	-7.46%	285.39%	-7.01%	-	-	-	-	-	-	Upgrade
Retained Earnings	-919.78	-802.61	-648.08	-502.54	-385.03	-320.54	-254.06	-197.92	-84.17	-36.72	Upgrade
Comprehensive Income	-0.47	-1.53	-0.71	-0.26	-0.73	-0.8	-0.96	-0.01	-0.01	0.01	Upgrade
Shareholders' Equity	83.47	181.52	316.19	434.35	174.96	201.17	184.03	215.6	252.59	149.48	Upgrade
Net Cash / Debt	33.88	94.53	206.58	404.49	138.82	206.08	190.49	222.17	259.08	159.4	Upgrade
Net Cash / Debt Growth	-64.17%	-54.24%	-48.93%	191.38%	-32.64%	8.19%	-14.26%	-14.25%	62.53%	28163.12%	Upgrade
Net Cash Per Share	3.36	9.52	21.07	47.51	21.66	33.58	43.63	61.30	101.68	136.82	Upgrade
Working Capital	77.86	158.35	295.83	413.57	156.46	198.04	183.07	215.38	254.42	154.81	Upgrade
Book Value Per Share	8.28	18.29	32.25	51.01	27.29	32.78	42.15	59.48	99.14	128.30	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).